imiquimod

GPTKB entity

Statements (43)
Predicate Object
gptkbp:instanceOf gptkb:drug
immune response modifier
gptkbp:approvedBy 1997
gptkbp:ATCCode D06BB10
gptkbp:brand gptkb:Zyclara
Aldara
gptkbp:CASNumber 99011-02-6
gptkbp:chemicalFormula C14H16N4
gptkbp:contraindication hypersensitivity to imiquimod
gptkbp:developedBy gptkb:3M_Pharmaceuticals
gptkbp:discoveredBy gptkb:3M
gptkbp:eliminationHalfLife 2 hours
gptkbp:excretion urine
feces
gptkbp:genericAvailable true
https://www.w3.org/2000/01/rdf-schema#label imiquimod
gptkbp:isApprovedDrug true
gptkbp:KEGGID D04568
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction TLR7 agonist
gptkbp:MeSH_ID D020253
gptkbp:metabolism hepatic
gptkbp:molecularWeight 240.3 g/mol
gptkbp:pregnancyCategory C (US)
B3 (Australia)
gptkbp:PubChem_CID CHEMBL685
57469
DB00724
gptkbp:routeOfAdministration topical
gptkbp:sideEffect edema
erosion
itching
burning
ulceration
erythema
local skin reactions
gptkbp:UNII F6F0HK1URN
gptkbp:usedFor gptkb:actinic_keratosis
external genital warts
superficial basal cell carcinoma
gptkbp:bfsParent gptkb:Zyclara
gptkb:actinic_keratosis
gptkbp:bfsLayer 7